Literature DB >> 19595673

Omentopexy enhances graft function in myocardial cell sheet transplantation.

Ryo Suzuki1, Fumiyuki Hattori, Yuji Itabashi, Masatoyo Yoshioka, Shinsuke Yuasa, Haruko Manabe-Kawaguchi, Mitsushige Murata, Shinji Makino, Kiyokazu Kokaji, Ryohei Yozu, Keiichi Fukuda.   

Abstract

Myocardial cell sheets (MCS) are a potentially valuable tool for tissue engineering aimed at heart regeneration. Several methods have recently been established for the fabrication of MCS. However, the lack of a sufficient blood supply has inhibited functional recovery of the MCS. To address this challenge, we combined MCS transplantation with omentopexy (OP), which utilizes omental tissue as a surgical flap. Rats were divided into five groups: sham, myocardial infarction (MI), MCS transplantation, OP, and MCS+OP. Histologic analysis revealed that MCS+OP drastically reversed MI-induced cardiac remodeling. Echocardiography revealed that MCS increased cardiac function, while OP had a synergistic beneficial effect with MCS transplantation. Immunofluorescence imaging showed that OP increased the survival of transplanted cardiomyocytes, and increased the blood supply through enhancement of angiogenesis and migration of small arteries into the MCS. Taken together, we concluded that OP is a promising strategy for the enhancement of graft function in MCS transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19595673     DOI: 10.1016/j.bbrc.2009.07.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  [Tissue engineering of vascularized myocardial prosthetic tissue. Biological and solid matrices].

Authors:  T Schilling; S Cebotari; I Tudorache; A Haverich
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

2.  Engineered Tissue Patch for Cardiac Cell Therapy.

Authors:  Jianyi Zhang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-08

Review 3.  A New Era of Cardiac Cell Therapy: Opportunities and Challenges.

Authors:  Ke Huang; Shiqi Hu; Ke Cheng
Journal:  Adv Healthc Mater       Date:  2018-12-13       Impact factor: 9.933

Review 4.  The current status of engineering myocardial tissue.

Authors:  Runqian Sui; Xiaobo Liao; Xinmin Zhou; Qi Tan
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 5.  Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium.

Authors:  Fumiyuki Hattori; Keiichi Fukuda
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

6.  Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.

Authors:  Shera Lilyanna; Eliana C Martinez; Thang D Vu; Lieng H Ling; Shu U Gan; Ai L Tan; Thang T Phan; Theo Kofidis
Journal:  Tissue Eng Part A       Date:  2013-02-28       Impact factor: 3.845

7.  Cardiosphere-derived cell sheet primed with hypoxia improves left ventricular function of chronically infarcted heart.

Authors:  Tohru Hosoyama; Makoto Samura; Tomoaki Kudo; Arata Nishimoto; Koji Ueno; Tomoaki Murata; Takashi Ohama; Koichi Sato; Akihito Mikamo; Koichi Yoshimura; Tao-Sheng Li; Kimikazu Hamano
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

8.  Gene manipulated peritoneal cell patch repairs infarcted myocardium.

Authors:  Wei Huang; Dongsheng Zhang; Ronald W Millard; Tao Wang; Tiemin Zhao; Guo-Chang Fan; Atif Ashraf; Meifeng Xu; Muhammad Ashraf; Yigang Wang
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

9.  Transplantation of engineered cardiac muscle flaps in syngeneic rats.

Authors:  Richard Tee; Wayne A Morrison; Gregory J Dusting; Guei-Sheung Liu; Yu Suk Choi; Sarah Tzu-Feng Hsiao; Rodney J Dilley
Journal:  Tissue Eng Part A       Date:  2012-09-04       Impact factor: 3.845

10.  Myocardial restoration: is it the cell or the architecture or both?

Authors:  Duc Thang Vu; Eliana C Martinez; Theo Kofidis
Journal:  Cardiol Res Pract       Date:  2012-02-16       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.